Skip to search formSkip to main contentSkip to account menu

SLC22A16 gene

Known as: CT2, CARNITINE TRANSPORTER 2, OKB1 
National Institutes of Health

Related topics

Related topics

2 relations
SLC22A12 geneSLC22A20 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Dose accumulation in IMRT for left breast cancer determined by applying deformation registration
Background To evaluate the dosimetric changes in the target volume and organs at risk (OARs) of patients with left breast cancer… 
2016
2016
Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients
BackgroundPrediction of response and toxicity of chemotherapy can help personalize the treatment and choose effective yet non… 
Review
2015
Review
2015
Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer
Background: The efficacy of second-line chemotherapy (CT2) after the failure of first-line chemotherapy (CT1) for advanced… 
2012
2012
Keys to successful progression directly from CT2 to ST3 in general surgery: a trainee's perspective
With a move to national recruitment in general surgery for ST3 places, what characteristics and attitudes are required of the CT2… 
2007
2007
Expression of Organic Cation Transporter SLC22A16 in Human Endometria
SLC22A16 is one of newly isolated organic cation transporters, which is responsible for uptake and transport of adriamycin into… 
2001
2001
[Determining the extent of intensive physical performance in patients with coronary heart disease].
Intensive physical exercise improves cardiac perfusion, skeletal muscle function and risk factors in patients with coronary… 
1996
1996
[Do we adequately use the sphygmomanometer for improving the prevention of arterial hypertension in primary care?].
OBJECTIVE To assess the monitoring of arterial pressure (AP) in non-hypertensive patients at a health centre and to compare the… 
1984
1984
Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues.
Monoclonal antibodies OKB1, OKB2, OKB4 and OKB7 have been previously shown to detect distinctive antigens displayed on B, but not… 
Review
1983
Review
1983
The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
Twenty-three T-cell neoplasms were divided, according to their reactivity with the OKT monoclonal antibodies as follows: Fourteen… 
1983
1983
Classification of human lymphocytes and monocytes with the OK series of monoclonal antibodies.
Membrane antigens expressed by either peripheral blood B cells, monocytes, or activated T cells have been identified by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)